Dexcom G6 Transmitter
MedicalSupply Endocrinology
PDI 00386270000385
General payments
$6,283,638
Research payments
$7,038,634
Through program year 2025, $6,283,638 in general payments and $7,038,634 in research payments were reported against Dexcom G6 Transmitter (Endocrinology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $1,279,585 | 53,555 |
| 2025 | Research | $433,642 | 82 |
| 2024 | General | $1,206,097 | 53,460 |
| 2024 | Research | $1,957,780 | 161 |
| 2023 | General | $1,055,406 | 50,405 |
| 2023 | Research | $1,781,090 | 246 |
| 2022 | General | $2,742,550 | 40,521 |
| 2022 | Research | $2,866,122 | 296 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 181 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 56 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
197,941 general · 785 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.